Quantification showed that only one tumor sample exhibited a significant number of HRCs co-expressing the LGR5 signature (7.79% sample SMC04, Fig. 1h) whereas five others included a minimal fraction (<3%) of cells marked by both LGR5 and the HRC gene programs. This evidence concerns the gene LGR5 and neoplasm.